P. P. Ovcaricek Et Al. , "Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2024
Ovcaricek, P. P. Et Al. 2024. Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING .
Ovcaricek, P. P., de Keizer, B., Campenni, A., Kreissl, M. C., Deandreis, D., TUNCEL, M., ... Giovanella, L.(2024). Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING .
Ovcaricek, Petra Et Al. "Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2024
Ovcaricek, Petra P. Et Al. "Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2024
Ovcaricek, P. P. Et Al. (2024) . "Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING .
@article{article, author={Petra Petranovic Ovcaricek Et Al. }, title={Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2024}